| The effectiveness of antiepileptic medications as prophylaxis of early seizure in patients with traumatic brain injury compared with placebo or no treatment: a systematic … R Wat, M Mammi, J Paredes, J Haines, M Alasmari, A Liew, VM Lu, ... World neurosurgery 122, 433-440, 2019 | 63* | 2019 |
| Protective effect of diosmin against doxorubicin-induced nephrotoxicity N Ali, AF AlAsmari, F Imam, MZ Ahmed, F Alqahtani, M Alharbi, ... Saudi Journal of Biological Sciences 28 (8), 4375-4383, 2021 | 47 | 2021 |
| Minimally invasive versus open surgery for the correction of adult degenerative scoliosis: a systematic review AM Lak, N Lamba, F Pompilus, I Yunusa, A King, I Sultan, J Amamoo, ... Neurosurgical review 44, 659-668, 2021 | 26 | 2021 |
| Physiologically-based pharmacokinetic modeling for single and multiple dosing regimens of ceftriaxone in healthy and chronic kidney disease populations: a tool for model … F Alasmari, MS Alasmari, HM Muwainea, HA Alomar, AF Alasmari, ... Frontiers in pharmacology 14, 1200828, 2023 | 19 | 2023 |
| Liver metabolomics and inflammatory profiles in mouse model of fentanyl overdose treated with beta-lactams F Alasmari, MS Alasmari, MA Assiri, M Alswayyed, S Rizwan Ahamad, ... Metabolites 13 (8), 965, 2023 | 9 | 2023 |
| Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Predicting Haloperidol Exposure in Healthy and Disease Populations MS Alasmari, F Alasmari, AF Alasmari, A Alshamsan, S Alsanea, ... Pharmaceutics 14 (9), 1795, 2022 | 5 | 2022 |
| Synthesis and Evaluation of Thiol-Conjugated Poloxamer and Its Pharmaceutical Applications M Zaman, S Saeed, R Imtiaz Bajwa, M Shafeeq Ur Rahman, SU Rahman, ... Pharmaceutics 13 (5), 693, 2021 | 5 | 2021 |
| A Physiologically Based Pharmacokinetic Model to Predict Systemic Ondansetron Concentration in Liver Cirrhosis Patients F Alqahtani, AH Alruwaili, MS Alasmari, SA Almazroa, KS Alsuhaibani, ... Pharmaceuticals 16 (12), 1693, 2023 | 2 | 2023 |
| Neuroinflammation and Neurometabolomic Profiling in Fentanyl Overdose Mouse Model Treated with Novel β-Lactam, MC-100093, and Ceftriaxone MS Alasmari, F Alasmari, SD Alsharari, AF Alasmari, N Ali, SR Ahamad, ... Toxics 12 (8), 604, 2024 | 1 | 2024 |
| Effects of beta lactams on behavioral outcomes of substance use disorders: a meta-analysis of preclinical studies MS Alasmari, OA Almohammed, AM Hammad, KA Altulayhi, BK Alkadi, ... Neuroscience 537, 58-83, 2024 | 1 | 2024 |
| Depression, anxiety, stress and its determinant factors, among adult population in Jeddah, Saudi Arabia. FM El-Gamal, HM Nadhrah, AA Abdulghani, M Alasmari, KS Alomari, ... Middle East Journal of Family Medicine 19 (1), 2021 | 1 | 2021 |
| The Clinical Pharmacokinetics and Pharmacodynamics of Glimepiride—A Systematic Review and Meta-Analysis M Azhar, MS Alasmari, A Zamir, H Saeed, F Alqahtani, T Ahmad, ... Pharmaceuticals 18 (1), 122, 2025 | | 2025 |
| Model-Based Dose Selection of a Sphingosine-1-Phosphate Modulator, Etrasimod, in Patients with Various Degrees of Hepatic Impairment MS Alasmari, F Alqahtani, F Alasmari, A Alsultan Pharmaceutics 16 (12), 1540, 2024 | | 2024 |
| Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region MS Alasmari, S Albusaysi, M Elhefnawy, AM Ali, K Altigani, M Almoslem, ... Saudi Pharmaceutical Journal, 102207, 2024 | | 2024 |
| Correction: Zaman et al. Synthesis and Evaluation of Thiol-Conjugated Poloxamer and Its Pharmaceutical Applications. Pharmaceutics 2021, 13, 693 M Zaman, S Saeed, R Imtiaz Bajwa, M Shafeeq Ur Rahman, SU Rahman, ... Pharmaceutics 16 (5), 690, 2024 | | 2024 |
| A Comparison of Cardiovascular Drugs Approved by the Us Food and Drug Administration and Health Canada (1980-2014) MS Alasmari, E Seoane-Vazquez, T Eguale, S Szeinbach Value in Health 19 (3), A58, 2016 | | 2016 |
| Trends in Approvals of New Drugs with Orphan Designation in the us (1983-2014) ST Alhawwashi, AM Alshahrani, SM Alsahali, MS Alasmari, ... Value in Health 18 (3), A302, 2015 | | 2015 |
